Lipid formulation

Exon Skipping Therapy for Functional Amelioration of Semifunctional Dystrophin in Becker and Duchenne Muscular Dystrophy

Chemical modification of short small hairpin RNAs for inhibition of gene expression

Compositions and methods for inhibiting expression of RRM2 genes

Therapeutic uses of inhibitors of RTP801

ANTISENSE OLIGONUCLEOTIDE MODULATION OF RAF GENE EXPRESSION

SOLUBLE THF RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE

Methods for treating chronic kidney disease

Compositions and Methods for Inhibiting Expression of Eg5 Gene

ANTISENSE OLIGONUCLEOTIDES (ODN) AGAINST SMAD7 AND USES THEREOF IN MEDICAL FIELD

Organic compositions to treat HSF1-related diseases

Organic compositions to treat HSF1-related diseases

dsRNA for treating viral infection

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

Organic compositions to treat Beta-ENaC-related diseases

Long-Acting DNA Dendrimers and Methods Thereof

RNA sequence-specific mediators of RNA interference

Treatment of neurological disorders

Potent anti APOB antisense compounds

Organic compositions to treat beta-ENaC-related diseases

Organic compositions to treat Beta-ENaC-related diseases

Anti-MicroRNA oligonucleotide molecules

Use of microrna-199b-5p in medical and diagnostic field

THERAPEUTIC USES OF INHIBITORS OF RTP801L

RNAi Modulation Of TGF-BETA And Therapeutic Uses Thereof

SYNTHETIC METHODS AND DERIVATIVES OF TRIPHOSPHATE OLIGONUCLEOTIDES

COMPOSITIONS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY NUCLEIC ACID CONTAINING A DICER SUBSTRATE AND A RECEPTOR BINDING REGION

Compositions and methods for inhibiting expression of huntingtin gene

Pharmaceutical Composition

MODULATION OF INFLAMMATORY RESPONSES BY FACTOR XI

Methods and compositions involving miRNA and miRNA inhibitor molecules

RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality

Lipids, lipid complexes and use thereof

Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means

Lipids and compositions for the delivery of therapeutics

OLIGONUCLEOTIDE COMPRISING AN INOSINE FOR TREATING DMD

MicroRNAs In Idiopathic Pulmonary Fibrosis

Reduced size self-delivering RNAi compounds

RNA sequence-specific mediators of RNA interference

RNA Interference Mediated Inhibition of GATA Binding Protein 3 (GATA3) Gene Expression Using Short Intefering Nucleic Acid (siNA)

Short interfering ribonucleic acid (siRNA) for oral administration

Short interfering ribonucleic acid (siRNA) for oral administration

RNA Interference Mediated Inhibition of the Thymic Stromal Lymphopoietin (TSLP) Gene Expression Using Short Interfering Nucliec Acid (siNA)

RNA Interference Mediated Inhibition of Signal Transducer and Activator of Transcription 1 (STAT1) Gene Expression Using Short Interfering Nucleic Acid (siNA)

Compositions and methods for inhibiting expression of a gene from the JC virus

Short interfering ribonucleic acid (siRNA) for oral administration

Means for inhibiting the expression of ANG2

Compositions and methods for inhibiting expression of mutant EGFR gene

RNA Interference Mediated Inhibition of Connective Tissue Growth Factor (CTGF) Gene Expression Using Short Interfering Nucleic Acid (siNA)

RNA Interference Mediated Inhibition of BTB and CNC Homology 1, Basic Leucine Zipper Transcription Factor 1 (BACH1) Gene Expression Using Short Interfering Nucleic Acid (siNA)

Optimized Methods For Delivery Of DSRNA Targeting The PCSK9 Gene

Compositions And Methods For Increasing Cellular Uptake Of RNAi Via SID-1

RNA sequence-specific mediators of RNA interference

RNA Interference Mediated Inhibition of Apoptosis Signal-Regulating Kinase 1 (ASK1) Gene Expression Using Short Interfering Nucleic Acid (siNA)

METHODS AND COMPOSITIONS FOR REPROGRAMMING CELLS

RNA Interference Mediated Inhibition of the Intercellular Adhesion Molecule 1 (ICAM-1) Gene Expression Using Short Interfering Nucleic Acid (siNA)

RNA Interference Mediated Inhibition of the Nerve Growth Factor Beta Chain (NGFB) Gene Expression Using Short Interfering Nucleic Acid (siNA)

RNA interference mediated inhibition of the FCεR1α gene

METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES

Modulation of exon recognition in pre-mRNA by interfering RNA structure

RNA interference mediating small RNA molecules

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

LIPIDS, LIPID COMPLEXES AND USE THEREOF

Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating RNA interference

MODULATION OF TRANSTHYRETIN EXPRESSION

USE OF MIR-126 FOR ENHANCING HEMATOPOIETIC STEM CELL ENGRAFTMENT, FOR ISOLATING HEMATOPOIETIC STEM CELLS, AND FOR TREATING AND MONITORING THE TREATMENT OF ACUTE MYELOID LEUKEMIA

ANTAGONISTS OF MIR-155 FOR THE TREATMENT OF INFLAMMATORY LIVER DISEASE

RNA sequence-specific mediators of RNA interference

SIRNA COMPOUNDS AND METHODS OF USE THEREOF

RNA Interference Mediated Inhibition of Epithelial Sodium Channel (ENaC) Gene Expression Using Short Interfering Nucleic Acid (siNA)

RNA sequence-specific mediators of RNA interference

Compositions and methods for inhibiting expression of the HAMP gene

Spinal muscular atrophy treatment via targeting SMN2 catalytic core

2'-F MODIFIED RNA INTERFERENCE AGENTS

Gene Silencing by Single-Stranded Polynucleotides

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

Organic compositions to treat beta-ENaC-related diseases

Reduced size self-delivering RNAi compounds

Methods of modulating mesenchymal stem cell differentiation

Method of Treating Neurodegenerative Disease

NOVEL siRNAS AND METHODS OF USE THEREOF

Nuclease resistant double-stranded ribonucleic acid

RNA sequence-specific mediators of RNA interference

RNA sequence-specific mediators of RNA interference

RNA sequence-specific mediators of RNA interference

RNA interference in skin indications

Neutral nanotransporters

SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE

dsRNA COMPOSITIONS AND METHODS FOR TREATING HPV INFECTION

Oligoribonucleotide inhibitors of Nrf2 and methods of use thereof for treatment of cancer

Compositions and methods for inhibiting expression of the PCSK9 gene

MODIFIED sIRNA MOLECULES AND USES THEREOF

Modulation of gene expression by oligomers targeted to chromosomal DNA

Compositions and methods for inhibiting expression of a gene from the ebola virus

Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases

Compositions and methods for silencing Ebola virus gene expression

Nuclease resistant external guide sequences for treating inflammatory and viral related respiratory diseases

Compositions and methods for silencing apolipoprotein B

COMPOSITIONS COMPRISING CMYC SIRNA AND METHODS OF USE THEREOF

Methods and means for treating DNA repeat instability associated genetic disorders

RNAi modulation of SCAP and therapeutic uses thereof

Compositions And Methods For Inhibiting Expression Of GSK-3 Genes

Inhibition of angiogenesis

Modulation of HSP47 expression

MODULATION OF TRANSFORMING GROWTH FACTOR-BETA 1 EXPRESSION

Minor groove binder (MGB)-oligonucleotide miRNA antagonists

Conjugates For Use In Hepatocyte Free Uptake Assays

Potentiation of autoimmune and inflammatory disease treatments by immune regulatory oligonucleotide (IRO) antagonists of TLR7 and TLR9

Organic compositions to treat HSF1-related diseases

Anti-MicroRNA oligonucleotide molecules

RNA interference mediated inhibition of vascular cell adhesion molecule (VCAM) gene expression using short interfering nucleic acid (siNA)

Chimeric Molecules to Modulate Gene Expression

Double-stranded polynucleotide

SMAD PROTEINS CONTROL DROSHA-MEDIATED MIRNA MATURATION

Compositions and methods for inhibiting expression of XBP-1 gene

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF IL-18 GENES

TOLL-LIKE RECEPTOR 9 AGONISTS FOR THE TREATMENT OF ANXIETY-RELATED DISORDERS AND INFLAMMATORY DISORDERS

Compositions and their uses directed to acetyl-CoA carboxylases

SYNTHETIC AGONISTS OF TLR9

NON-NATURAL RIBONUCLEOTIDES, AND METHODS OF USE THEREOF

Antiviral Oligonucleotides Having a Conserved G4 Core Sequence

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Nav1.8 GENE

Methods and compositions for reducing viral genome amounts in a target cell

Materials and Methods for Treatment of Cancer

Compositions and Methods for Inhibiting Expression of TGF-BETA Receptor Genes

Interfering RNA molecules

DELIVERY OF RNAI CONSTRUCTS TO OLIGODENDROCYTES

Antisense antiviral compound and method for treating influenza viral infection

Therapeutic uses of inhibitors of RTP801

RNA interference mediating small RNA molecules

Compositions and methods for inhibiting expression of IKK-B gene

Double-stranded RNA directed to CASP2 and methods of use thereof

SOLUBLE TNF RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE

siRNA compounds for inhibiting NRF2

Modification of MYD88 splicing using modified oligonucleotides

METHOD OF TREATING NEURODEGENERATIVE DISEASE

RNA antagonist compounds for the modulation of PIK3CA expression

Lipid formulations for nucleic acid delivery

MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

RNAi Modulation of the RHO-A Gene and Uses Thereof

RNA interference mediating small RNA molecules

RNA interference mediated inhibition of muscarinic colinergic receptor gene expression using short interfering nucleic acid (siNA)

Compounds and methods for modulating expression of SGLT2

RNA interference mediating small RNA molecules

RNA interference mediating small RNA molecules

Compositions and methods for inhibiting expression of a gene from the ebola virus

Modulation of apolipoprotein C-III expression

Aptamer therapeutics useful in the treatment of complement-related disorders

RNA interference mediating small RNA molecules

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

Use of antisense oligonucleotides to effect translation modulation

Modified RNAi polynucleotides and uses thereof

CCR2 INHIBITORS FOR TREATING CONDITIONS OF THE EYE

Compositions and methods for inhibiting expression of CD45 gene

Modulation of T cell signaling threshold and T cell sensitivity to antigens

Methods of treating eye diseases in diabetic patients

RNA interference mediating small RNA molecules

Methods and compositions for the specific inhibition of KRAS by asymmetric double-stranded RNA

RNA interference mediating small RNA molecules

RNA interference mediated inhibition of human immunodeficiency virus (HIV) gene expression using short interfering nucleic acid (siNA)

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 GENE

RNA interference mediating small RNA molecules

Methods and compositions for inhibition of immune responses and autoimmunity

Antisense oligonucleotides targeted to the coding region of thymidylate synthase and uses thereof

Peptide-conjugated oligonucleotide therapeutic and method of making and using same

METHODS AND COMPOSITONS FOR ANTISENSE VEGF OLIGONUCLEOTIDES

Pharmaceutical compositions for treatment of HCV patients that are poor-responders to interferon

Lipid formulation

RNA Antagonist Compounds for the Modulation of MCL-1

Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical field

RNA interference mediating small RNA molecules

Nucleic acid modulators of glycoprotein VI

RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)

RNA INTERFERENCE MEDIATED INHIBITION OF ADENOSINE A1 RECEPTOR (ADORA1) GENE EXPRESSION USING SHORT INTERFERING RNA

Antibodies directed to mGluR7

Compositions and methods for inhibiting expression of Huntingtin gene

RNA interference mediating small RNA molecules

RNAi MODULATION OF HIF-1 AND THERAPUTIC USES THEREOF

NOVEL SIRNA STRUCTURES

Micrornas that regulate muscle cell proliferation and differentiation

Anti-microRNA oligonucleotide molecules

Pharmaceutical composition comprising anti-mirna antisense oligonucleotide

Micro-RNA family that modulates fibrosis and uses thereof

RECEPTOR TARGETED OLIGONUCLEOTIDES

METHODS AND COMPOSITIONS FOR MODULATING TISSUE FACTOR

Therapeutic uses of inhibitors of RTP801

Efficient Nuclear Delivery of Antisense Oligonucleotides or siRNA In Vitro and In Vivo by Nano-Transforming Polymersomes

Rnai Therapeutic for Respiratory Virus Infection

Modulators of pharmacological agents

DSRNA COMPOSITIONS AND METHODS FOR TREATING HPV INFECTIONS

Antisense modulation of kinesin-like 1 expression

RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA)

RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

Compositions and methods for inhibiting expression of a gene from the JC virus

RNA interference mediated inhibition of myostatin gene expression using short interfering nucleic acid (siNA)

RNA INTERFERENCE MEDIATED INHIBITION OF CHROMOSOME TRANSLOCATION GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

siRNA sequence-independent modification formats for reducing off-target phenotypic effects in RNAi, and stabilized forms thereof

Chemically modified oligonucleotides for use in modulation micro RNA and uses thereof

Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation

RNAi inhibition of alpha-ENaC expression

RNAi inhibition of alpha-ENaC expression

AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL

RNAi modulation of APOB and uses thereof

RNAi inhibition of alpha-ENaC expression

RNAi inhibition of alpha-ENaC expression

METHOD FOR ENHANCING SERUM STABILITY AND LOWERING IMMUNE RESPONSE OF SIRNA DOWN-REGULATING GENE EXPRESSION OF HBV OR HCV

Nicked or gapped nucleic acid molecules and uses thereof

OLIGONUCLEOTIDE COMPOSITIONS FOR THE TREATMENT OF ALZHEIMER'S DISEASE

Compositions and methods for inhibiting expression of the HAMP gene

Method of Treating Neurodegenerative Disease

INFLUENZA THERAPEUTIC

Modulators of coagulation factors

RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)

MODIFIED POLYNUCLEOTIDES FOR USE IN RNA INTERFERENCE

RNAi inhibition of alpha-ENaC expression

EXTENDED DICER SUBSTRATE AGENTS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION

METHODS AND MEANS FOR TREATING DNA REPEAT INSTABILITY ASSOCIATED GENETIC DISORDERS

RNAi modulation of SCAP and therapeutic uses thereof

RNA interference mediated inhibition of protein tyrosine phosphatase-1B (PTP-1B) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)

dsRNA For Treating Viral Infection

Compositions and methods for modulating angiogenesis

COMPOSITIONS AND METHODS FOR INHIBITING GENE SILENCING BY RNA INTERFERENCE

dsRNA FOR TREATING VIRAL INFECTION

ANTIVIRAL OLIGONUCLEOTIDES TARGETING RSV

Extended dicer substrate agents and methods for the specific inhibition of gene expression

Enhanced biotherapeutic production using inhibitory RNA

ANTIVIRAL OLIGONUCLEOTIDES TARGETING VIRAL FAMILIES

RNA interference mediated treatment of alzheimer's disease using short interfering nucleic acid (siNA)

GNAQ targeted dsRNA compositions and methods for inhibiting expression

Methods and Compositions for Prevention or Treatment of RSV Infection Using Modified Duplex RNA Molecules

Therapeutic uses of inhibitors of RTP801L

MODULATION OF SID-1 EXPRESSION

RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)

OLIGORIBONUCLEOTIDES AND RIBONUCLEASES FOR CLEAVING RNA

OLIGONUCLEOTIDE SYSTEMS FOR TARGETED INTRACELLULAR DELIVERY

RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)

Pure miRNA Sample Preparation Method

Antisense oligonucleotides directed against connective tissue growth factor and uses thereof

RNA interference mediated inhibition of GRB2 associated binding protein (GAB2) gene expression using short interfering nucleic acid (siNA)

MODULATION OF eIF4E EXPRESSION

Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly or abnormally expressed gene

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF FACTOR VII GENES

RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)

Compositions and methods for inhibiting expression of transthyretin

RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)

Therapeutic targets and molecules

NUCLEIC ACID COMPOUNDS FOR INHIBITING ERBB FAMILY GENE EXPRESSION AND USES THEREOF

RNA interference mediated inhibition of muscarinic colinergic receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of matrix metalloproteinase 13 (MMP13) gene expression using short interfering nucleic acid (siNA)

Compositions and methods for gene silencing

Tripartite oligonucleotide complexes and methods for gene silencing by RNA interference

MODULATION OF MYELOID DIFFERENTATION PRIMARY RESPONSE GENE 88 (MYD88) EXPRESSION BY ANTISENSE OLIGONUCLEOTIDES

METHODS OF MODULATING EPITHELIAL-MESENCHYMAL TRANSITION AND MESENCHYMAL-EPITHELIAL TRANSITION IN CELLS AND AGENTS USEFUL FOR THE SAME

Compositions and Methods for Inhibiting Expression of Eg5 and VEGF Genes

NUCLEIC ACID COMPOUNDS FOR INHIBITING RAS GENE EXPRESSION AND USES THEREOF

MODULATION OF TOLL-LIKE RECEPTOR 8 EXPRESSION BY ANTISENSE OLIGONUCLEOTIDES

Method of treating a cancer by administering A 2′,5′-oligoadenylate analog

Platelet derived growth factor (PDGF) nucleic acid ligand complexes

Compositions and their uses directed to PTPR alpha

Compositions and methods for inhibiting expression of the MYC gene

Short interfering ribonucleic acid (siRNA) with improved pharmacological properties

RNA INTERFERENCE MEDIATING SMALL RNA MOLECULES

Optimized Methods For Delivery Of DSRNA Targeting The PCSK9 Gene

COMPOSITIONS AND METHODS FOR SPECIFICALLY SILENCING A TARGET NUCLEIC ACID

Aptamer against midkine and use thereof

Pharmaceutical Composition

Modulation of gene expression through endogenous small RNA targeting of gene promoters

Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin

COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF CRP

COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF SGLT2

Compounds and methods for modulating expression of PTP1B

Modulation of exon recognition in pre-mrna by interfering with the binding of sr proteins and by interfering with secodary rna structure

RNAi modulation of ApoB and uses thereof

METHODS TO TREAT OR PREVENT HORMONE-RESISTANT PROSTATE CANCER USING siRNA SPECIFIC FOR PROTOCADHERIN-PC, OR OTHER INHIBITORS OF PROTOCADHERIN-PC EXPRESSION OR ACTIVITY

Compounds and methods for modulating expression of GCCR

Compounds and methods for modulating expression ApoB

Compounds and methods for modulating expression of GCGR

Compounds and methods for modulating expression of PCSK9

Means for inhibiting the expression of protein kinase 3

RNA Interference Mediated Inhibition Of Interleukin and Interleukin Gene Expression Using Short Interfering Nucleic Acid (siNA)

COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF DGAT2

Silencing of polo-like kinase expression using interfering RNA

Compositions and methods for delivering RNAI using lipoproteins

Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof

RNA interference mediated inhibition of respiratory syncytial virus (RSV) expression using short interfering nucleic acid (siNA)

STABILIZED SIRNAS AS TRANSFECTION CONTROLS AND SILENCING REAGENTS

Compositions and methods for inhibiting expression of XBP-1 gene

ANTISENSE OLIGONUCLEOTIDES AGAINST ACETYLCHOLINESTERASE FOR TREATING INFLAMMATORY DISEASES

HUMAN RNASE III AND COMPOSITIONS AND USES THEREOF

Means and method for inducing exon-skipping

Conjugates and compositions for cellular delivery

Compositions and methods for inhibiting expression of factor VII gene

DELIVERY OF POLYNUCLEOTIDE AGENTS TO THE CENTRAL NERVOUS SYSTEM

Compositions and methods for inhibiting expression of Nav1.8 gene

RNA interference mediated inhibition of CXCR4 gene expression using short interfering nucleic acid (siNA)

RNA INTERFERENCE MEDIATED INHIBITION OF B-CELL CLL/LYMPHOMA-2 (BCL2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

dsRNA compositions and methods for treating HPV infection

RNA Interference Mediated Inhibition of Adenosine A1 Receptor (ADORA1) Gene Expression Using Short Interfering Nucleic Acid (siNA)